Description
The Defense Health Agency is seeking information from potential sources to provide radiopharmaceuticals to the Naval Medical Center Portsmouth, Naval Medical Center Camp Lejeune, and Naval Health Clinic Jacksonville. The contract will be for a period of 5 years, from October 1, 2026, to September 30, 2031. The contractor will be required to provide radiopharmaceuticals on an as-needed basis to each of the medical facilities. The contractor must be able to deliver the radiopharmaceuticals within a specified timeframe, maintain a 95% on-time delivery rate, and comply with all applicable regulations and guidelines.
Some key requirements include:
• Providing radiopharmaceuticals for cancer patients, including Tc-99m Medronate, Tc-99m Mebrofenin, and Tc-99m Pentetate
• Delivering radiopharmaceuticals to the medical facilities on a daily basis, with the option for emergency deliveries
• Maintaining accurate records and providing reports as required
• Complying with all applicable regulations, including those related to radiation safety and handling of radioactive materials